-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

602A.O2.6 602. Myeloid Oncogenesis: Basic: Cellular Mechanisms and Therapeutic Strategies

Symposia: Myeloid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Acute Myeloid Malignancies, AML, MDS, Apoptosis, Translational Research, MPN, CHIP, CML, Genomics, Bioinformatics, Chronic Myeloid Malignancies, Hematopoiesis, Diseases, Metabolism, Myeloid Malignancies, Biological Processes, Molecular biology, Technology and Procedures, Pathogenesis, Omics technologies
Saturday, December 7, 2024: 9:30 AM-11:00 AM
Room 6A (San Diego Convention Center)
Moderators:
Elvin Wagenblast, PhD, Icahn School of Medicine and Diu T.T. Nguyen, PhD, Barts Cancer Institute, Queen Mary University of London
Disclosures:
No relevant conflicts of interest to declare.
9:30 AM

Lia N'guyen1*, Emeline Boet, PhD2*, Camille Montersino1*, Claire Burny1*, Stéphane Audebert, PhD1*, Luc Camoin, PhD1*, Rémy Castellano, PhD1*, Sylvain Garciaz, MD, PhD1*, Atsushi Iwama, MD, PhD3,4, Jean-Emmanuel Sarry, PhD2*, Estelle Duprez, PhD1* and Mathilde Poplineau1*

1Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, INSERM UMR1068, CNRS UMR7258, Aix Marseille Université U105, Marseille, France
2Centre de Recherche en Cancérologie de Toulouse, INSERM, Toulouse, France
3Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
4University of Tokyo, Tokyo, TKY, Japan

9:45 AM

Jie Sun1*, Shaoqi Zhang, PhD2*, Ran Du3*, Yue Zang3*, Yongjin Liu4*, Zhihui Li5*, Diange Jin2*, Rong Fan3*, Lina Liu, MS6*, Jun Liu7*, Yue Liang, MS3*, Shang Lou3*, Xiaoqing Zou8*, Bian Wei3*, Yin Zhao, MS3*, Rong Wang2*, Yanan Wang3*, Tong Wu, MD5, Jinyan Huang4*, Hongshan Guo2,3* and Shanshan Pei, PhD9,10*

1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Bone Marrow Transplantation Center of The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
4Biomedical big data center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
5Department of Bone Marrow Transplantation, Beijing GoBroad Boren Hospital, Beijing, China
6Bone Marrow Transplantation Center of The First Affiliated Hospital, Zhejiang University School of Medicine, HAMILTON, ON, Canada
7Liangzhu Laboratory, Zhejiang University, Hangzhou, China
8Liangzhu Laboratory, Zhejiang University School of Medicine, hangzhou, China
9Liangzhu Laboratory, Zhejiang University, Hangzhou, Zhejiang, China
10Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, hangzhou, China

10:00 AM

Mark J Althoff, BS1, Mohd Minhajuddin, PhD1*, Brett M Stevens, PhD, BS1*, Austin E Gillen, PhD1*, Regan Miller, MS1*, Ana Vujovic, PhD1*, Sweta B Patel, PhD1*, William Showers, MS1*, Stephanie Gipson, MS1*, Monika Dzieciatkowska, Ph.D1*, Jana M Ellegast, MD2,3,4, Tristen Wright, PhD5,6*, Kimberly Stegmaier, MD2,3,7, Joseph T Opferman, PhD5,6* and Craig T Jordan, PhD1

1Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
2Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Department of Medical Oncology, University Hospital of Zurich, Zurich, Switzerland
5Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN
6Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN
7Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA

10:15 AM

Dongxu Jiang, PhD1,2, Yahan Zhang, MS1,2, Xiaorong Gu, PhD2*, Daniel J Vail1*, Jill Durkin1*, Simon Schlanger, MS1*, J. Joseph Melenhorst, PhD3, Jaroslaw Maciejewski4 and Babal K. Jha, PhD1,2

1Center for Immunotherapy & Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Center for Immunotherapy and Precision Immuno-Oncology, Cell Therapy & Immuno-Engineering Program, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
4Taussig Cancer Center, Cleveland, OH

10:30 AM

Jonas Fullin, MSc1*, Ebru Topçu, MSc1*, Roman R. Schimmer, MD2*, Nancy Klemm, MSc1*, Karolina Zielinska, PhD1*, Christian Koch, MD1*, Francisco Caiado, PhD2*, Cyril Doerdelmann, PhD3*, Melissa Lock, MSc2*, Joelle Tchinda, PhD4, Markus G. Manz, MD1, Massimo Lopes, PhD3* and Steffen Boettcher, MD1*

1Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
2Department for Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
3Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland
4Laboratory for Oncology, Children's Hospital Zurich, Zurich, Switzerland

10:45 AM

Maria Latacz1,2*, Yansu Song, PhD1*, Yi Hao, PhD1*, Marta Cykowiak, PhD1*, Julia Kirylczuk, MS1*, Jing Hu, PhD1*, Bi Shi, PhD1* and Hao Jiang, PhD1,3

1Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA
2Faculty of Medicine, Collegium Medicum, Univeristy of Warmia and Mazury, Olsztyn, Poland
3UVA Comprehensive Cancer Center, University of Virginia School of Medicine, Charlottesville, VA

*signifies non-member of ASH